Type 2 diabetes patients starting treatment with medications in a class of drugs called sodium-glucose cotransporter-2 inhibitors or SGLT2i drugs need to be aware of a recent FDA communication warning that these drugs have been associated with amputations and the development of flesh-eating bacterial infection attacks the genital tissues. Though typically diagnosed as … [Read more...]

Certain type 2 diabetes medications called SGLT2 inhibitors have been reported to cause amputations and a severe and potentially life-threatening bacterial infection that destroys and decays the flesh of the genitals. The FDA is seeking more information from physicians who diagnose and patients who suffer gangrene and amputations from the deadly bacterial infection and are … [Read more...]

The U.S. Food and Drug Administration issued a warning to physicians, patients, and the public stating that certain diabetes medications can cause some patients to develop a flesh-eating infection in their genital and anal tissues. This infection, called necrotizing fasciitis of the perineum or Fournier’s gangrene, is very dangerous as it can rapidly progress to destroy the … [Read more...]

An SGLT2i is a medication that inhibits the kidneys from reabsorbing glucose and allows it to be excreted in urine. These types of medications are used in the treatment of type 2 diabetes. Unfortunately, this class of drugs has been linked to a severe flesh-eating infection that attacks genital and anal tissues. Patients who develop this infection after starting treatment with … [Read more...]

Fournier’s gangrene is a type of flesh-eating infection that affects the genital and anal tissue. It is a rapidly progressing infection that can quickly lead to severe and life-threatening consequences. Patients who are treated for type 2 diabetes with an SGLT2 inhibitor have an increased risk of developing Fournier’s gangrene. Patients who develop the dangerous condition may … [Read more...]